FC Barcelona has announced its Brazilian player Rafael 'Rafinha' Alcantara would be sidelined for six months after he successfully underwent a cruciate ligament right knee operation.
"Rafinha has been operated on successfully by doctors Ramon Cugat and Ricard Pruna following the cruciate ligament right knee injury that he suffered in the game against AS Roma," the Spanish club announced in a statement on its website on Tuesday, reports Efe.
The midfielder sustained the injury after a strong tackle by Belgian Radja Nainggolan of AS Roma in the first match of the UEFA Champions League tie, which ended 1-1.
"The player is expected to be out for around six months," the statement added.
Barcelona had to ask the Spanish Football Federation and FIFA to allow the Catalan club to register Turkish player Arda Turan to replace the Brazilian midfielder because of sanctions imposed on the Spanish club not to sign new players until January, 2016.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app